percept is a non-invasive prenatal screening test (NIPT) that analyses cell-free fetal DNA from the placenta. percept is a genome wide NIPT, looking for conditions across all 23 pairs of chromosomes.

This test can identify pregnancies at increased chance of having a chromosome condition such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13) and sex chromosome conditions like Turner and Klinefelter syndrome.

percept is suitable for:

• women of any age
• twin and triplet pregnancies
• balanced translocation carriers
• donor egg/sperm pregnancies.

To order this test please refer to the information on the VCGS website and use the VCGS request form.

Please note: This service is not Medicare rebatable and patients will be charged. Out of Pocket cost - $449.00

PLEASE NOTE: Over the holiday period, to ensure timely results and to avoid potential recollection, VCGS are implementing the following cut-off dates for the collection and sending of specimens.

*Do not collect samples on Friday, 22nd of December 2023

Instructions for: Metropolitan and Regional Collections Staff

Collection cannot be performed before 10 weeks of gestation.

For collection use the NIPT Percept collection kit. Blood collected into an EDTA or ACD (or any other tube) is unacceptable. Please check the expiry of the tube prior to collection.

Sample: Cell free DNA BCT (Streck) tube

A minimum of 7mL of whole blood is required (see below) to allow for sufficient sample for analysis. A sample cannot be collected into two tubes and combined by the laboratory to make a total of 7mL.